Trinity Capital provides $45M in growth capital to Rapid Micro Biosystems

Trinity Capital (TRIN) announced the commitment of $45 million in growth capital to Rapid Micro Biosystems (RPID). “We are pleased to partner with Trinity Capital, who shares our vision of automating manual microbial quality control testing methods used in biopharma manufacturing,” said Robert Spignesi, President and CEO of Rapid Micro Biosystems. “This facility significantly strengthens our financial position and supports our continued focus on long-term revenue growth, margin expansion, and increasing shareholder value.”